Scope of GSK's AI work across discovery and development

In this episode, hosts Navraj Nagra and Alex Devereson speak to Kim Branson, senior vice president and global head of AI and machine learning at GSK. They discuss how these emerging technologies are being used to potentially reshape how drugs are developed and about the complexities AI and machine learning introduce in data management, cross-functional collaboration, and responsible innovation.

See www.mckinsey.com/privacy-policy for privacy information